Navigation Links
Moderate alcohol consumption in middle age can lower cardiac risk
Date:3/7/2008

New York, March 7, 2008 Previous studies have pointed out the benefits of moderate alcohol consumption as a factor in lowering cardiovascular risk. In a study conducted by the Department of Family Medicine at the Medical University of South Carolina and published in the March 2008 issue of The American Journal of Medicine, researchers found that middle-aged non-drinkers who began consuming moderate amounts of alcohol saw an immediate benefit of lower cardiac disease morbidity with no change in mortality after four years.

Studying 7,697 people between 45 and 64 who were non-drinkers and who were participating in the Atherosclerosis Risk in Communities (ARIC) study over a 10 year period, the authors found that 6% began moderate alcohol consumption (1 drink per day or fewer for women and 2 drinks per day or fewer for men) during the follow-up period. After 4 years of follow-up, new moderate drinkers had a 38% lower chance of developing cardiovascular disease than did their non-drinking counterparts. Even after adjusting for physical activity, Body Mass Index, demographic and cardiac risk factors, this difference persisted.

The study also identified a subset of new drinkers who consumed only wine. When comparing non-drinkers to wine-only drinkers, drinkers of other types of alcohol, and heavy drinkers, the wine-only drinkers had the most significant reduction in cardiovascular events. Drinkers of other types of alcohol also had an advantage over non-drinkers, but the difference did not reach statistical significance.

Writing in the article, Dana E. King, MD, MS, states, A substantial cardiovascular benefit from adopting moderate alcohol drinking in middle age appears supported by the current study. Any such benefit must be weighed with caution against the known ill consequences of alcohol consumption. While caution is clearly warranted, the current study demonstrated that new moderate drinking lowers the risk of cardiovascular disease without
'/>"/>

Contact: Pamela Poppalardo
ajmmedia@elsevier.com
212-633-3944
Elsevier Health Sciences
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. A Drug With Efficacy Superior to That of Memantine Would Earn up to a 50% Patient Share in the Moderate-to-Severe Alzheimers Disease Drug Market
2. Moderate Aerobic Fitness Levels May Cut Stroke Risk
3. Gene variant linked to moderated symptoms of beta-thalassemia
4. Moderate Exercise Cuts Risk of Metabolic Syndrome
5. New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD
6. Research Shows Alcohol Can Benefit the Hearts of New Drinkers
7. U of Minn researchers find primary alcohol prevention programs are needed for tweens
8. Alcoholics underestimate the risk of bleeding
9. Gene variant predicts medication response in patients with alcohol dependence
10. Eye Blinks May ID Fetal Alcohol Exposure
11. Parental Drinking Boosts Teen Alcohol Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...studies of its kind, researchers say mindful medit...udy, led by doctors at the University of //Wiscons...ion impacts the left side of the brain and has a h...ted 25 people in a work environment with healthy e...
...ake certain types of painkillers, including aspiri...cientists said on Friday. But Paracetomol is not a...regnancy, they added. Researchers in California in...r they became pregnant and asked them about their ...
... achy and don't know why? You could have sinusitis...fflicting Americans.That's the conclusion of new r...in this week's issue of the Archives of Internal M...nist at Georgetown University Medical Center, surv...
...eart attack, the most important thing they can do ...e damage to their heart is to get help as soon as ...to the National Heart, Lung, and Blood Institute, ... when they experience heart attack symptoms becaus...
Other Medicine News:Health News:Recognize Heart Attack Signs 2
(Date:10/6/2008)...- Pharmasset, Inc.,(Nasdaq:... is joining the,Company as Vice President of Inves...ith will be responsible for all investor relations...cial Officer Kurt,Leutzinger., Most recently, Dr....gy,Analyst at JPMorgan Securities, and has been an...
(Date:10/6/2008)...eature children, parents discussing clinical ... Oct. 6 /PRNewswire-USNewswire/ -- From asthma and...en saves lives and improves their,health and well-... of,Health (NIH), "Children and Clinical Studies",...gov ), offers parents and health,care providers an...
(Date:10/6/2008)...t. 6 /- Genaera,Corporation...ond Phase 1,clinical trial of trodusquemine (MSI-1...ent of type 2 diabetes and obesity. MSI-1436 is a ...rget that controls the function,of both the leptin...rease,appetite. In the study, MSI-1436 was found t...
(Date:10/6/2008)...Eliminate 6 Weeks of Radiation Therapy -, Event: W...rnet Wednesday, October 22, 2008, 3 - 4 p.m. by... HAMPTON, Va., Oct. 6 / Questions rac... with breast cancer in May. Would she have the,tum...on or chemotherapy?, , To view the Multimedia Ne...
Breaking Medicine Technology:Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 2Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 4Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2AvMeds New 2008 Plans Priced 50 25 Less 11514 1AvMeds New 2008 Plans Priced 50 25 Less 11514 2The beauty bias 3A Can people love the one they are compatible with 3F 11512 1The beauty bias 3A Can people love the one they are compatible with 3F 11512 21 year results of bronchial thermoplasty in refractory asthma 11510 11 year results of bronchial thermoplasty in refractory asthma 11510 2Handbook of cancer prevention launched by ESMO 11508 1Handbook of cancer prevention launched by ESMO 11508 2
...ularly engineered,therapy selectively embeds a gen...tumors, inhibits metastasis, and prolongs survival...University of,Texas M. D. Anderson Cancer Center r...s vehicle, or vector, is so targeted and robust in...d for therapy and,perhaps for imaging," notes seni...
...nol,s (SP-233) Ability to Clear Brain,Plaque and E..., In Vivo ,Proof of Concept, Study Proposes Direct...and Memory Recovery , LAS VEGAS, July 10, 2007 (PR...MEX:LIV), a developer of innovative drugs,is plea...-233),efficacy in its ability to dramatically decr...
Other Medicine Technology:Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell 2Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell 3Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell 4Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell 5Samaritan's Alzheimer's Drug Caprospinol Suggests Brain May be Able,to Heal From Alzheimer's Disease 2Samaritan's Alzheimer's Drug Caprospinol Suggests Brain May be Able,to Heal From Alzheimer's Disease 3
IMMULITE and IMMULITE 1000 assays are designed for use with the IMMULITE and IMMULITE 1000, continuous random access immunoassay analyzers which offer simplicity in both design and operation. IMMULIT
The C-Reactive Protein (CRP) assay is used for the quantitative analysis of C-reactive protein in human serum and plasma. Kit is for use with the Abbot Laboratories Aeroset, ARCHITECT c8000 or ARCHI
LabDAQ3 opens new windows for the laboratory in flexibility, communication, security, and value. Users can easily move from one function to another. You can review results, validate QC, order tests,
...y for faster, easier, and more accurate automated ...lizes the latest digital FireWire technology, allo... Its ease of use allows technicians to read plates...reduction frees technicians to perform other impor...
Medicine Products: